Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Individuals with pre-existing medical conditions face substantially elevated risks, including those with diabetes (particularly type 1), cardiovascular disease, eating disorders, chronic kidney disease, pregnancy, under-18s, and frail older adults
NHS (2024)
Country of Origin: USA Manufacturer/Importer/Packed By: Now Foods Country of Origin: USA Manufacturer/Importer/Packed By: Now Foods
I had no idea what it was
Rated 4.9 out of 5 based on 11 customer ratings (11 customer reviews) 560.00 AED Blend composition 4 actives 80mg total peptide content GHK-Cu 50mg 62.5% BPC-157 10mg 12.5% TB-500 10mg 12.5% KPV 10mg 12.5% Purity 99.47% Form Lyophilized powder Certificate of Analysis 99.47% Tested purity 99.47% Measured content 95.53mg Test date 14/06/2026 Current batch NVKL80-01052026 Issued by an accredited independent laboratory and tied to this peptide
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States
US$ 27.39
US$ 29.76
US$ 26.89
US$ 23.83
